Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Bhupendra Doctor

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Concepts & Ideas

Kinetics

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
36
Saxena, Ashima
26
Gordon, Richard
17
Ashani, Yacov
12
Taylor, Palmer
11
Sun, Wei
11
Luo, Chunyuan
11
Maxwell, Donald
9
Radic, Zoran
9
Nambiar, Madhusoodana
6
Raveh, Lily
6
Chilukuri, Nageswararao
6
Lenz, David
6
Lockridge, Oksana
5
Ved, Haresh
4
Sciuto, Alfred

Sign-in to see all Coauthors

Publications

TOP 3
Sun Wei; Luo Chunyuan; Naik Ramachandra S; Doctor Bhupendra P; Saxena Ashima
Pharmacokinetics and immunologic consequences of repeated administrations of purified heterologous and homologous butyrylcholinesterase in mice.
Chilukuri Nageswararao; Duysen Ellen G; Parikh Kalpana; diTargiani Robert; Doctor Bhupendra P; Lockridge Oksana; Saxena Ashima
Adenovirus-transduced human butyrylcholinesterase in mouse blood functions as a bioscavenger of chemical warfare nerve agents.
Che Magnus M; Conti Michele; Chanda Soma; Boylan Megan; Sabnekar Praveena; Rezk Peter; Amari Ethery; Sciuto Alfred M; Gordon Richard K; Doctor Bhupendra P; Nambiar Madhusoodana P
Post-exposure treatment with nasal atropine methyl bromide protects against microinstillation inhalation exposure to sarin in guinea pigs.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Bhupendra Doctor (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Sun Wei; Luo Chunyuan; Naik Ramachandra S; Doctor Bhupendra P; Saxena Ashima
Pharmacokinetics and immunologic consequences of repeated administrations of purified heterologous and homologous butyrylcholinesterase in mice.
Life sciences 2009;85(17-18):657-61.
2009: Chilukuri Nageswararao; Duysen Ellen G; Parikh Kalpana; diTargiani Robert; Doctor Bhupendra P; Lockridge Oksana; Saxena Ashima
Adenovirus-transduced human butyrylcholinesterase in mouse blood functions as a bioscavenger of chemical warfare nerve agents.
Molecular pharmacology 2009;76(3):612-7.
2009: Che Magnus M; Conti Michele; Chanda Soma; Boylan Megan; Sabnekar Praveena; Rezk Peter; Amari Ethery; Sciuto Alfred M; Gordon Richard K; Doctor Bhupendra P; Nambiar Madhusoodana P
Post-exposure treatment with nasal atropine methyl bromide protects against microinstillation inhalation exposure to sarin in guinea pigs.
Toxicology and applied pharmacology 2009;239(3):251-7.
2009: Katos Alexandre M; Conti Michele; Moran Theodore S; Chon Thomas W; Gordon Richard K; Sciuto Alfred M; Doctor Bhupendra P; Nambiar Madhusoodana P
Acute microinstillation inhalation exposure to soman induces changes in respiratory dynamics and functions in guinea pigs.
Inhalation toxicology 2009;21(7):1-10.
2008: Saxena Ashima; Luo Chunyuan; Doctor Bhupendra P
Developing procedures for the large-scale purification of human serum butyrylcholinesterase.
Protein expression and purification 2008;61(2):191-6.
2008: Sun Wei; Doctor Bhupendra P; Lenz David E; Saxena Ashima
Long-term effects of human butyrylcholinesterase pretreatment followed by acute soman challenge in cynomolgus monkeys.
Chemico-biological interactions 2008;175(1-3):428-30.
2008: Chilukuri Nageswararao; Sun Wei; Naik Ramachandra S; Parikh Kalpana; Tang Lin; Doctor Bhupendra P; Saxena Ashima
Effect of polyethylene glycol modification on the circulatory stability and immunogenicity of recombinant human butyrylcholinesterase.
Chemico-biological interactions 2008;175(1-3):255-60.
2008: Saxena Ashima; Sun Wei; Dabisch Paul A; Hulet Stanley W; Hastings Nicholas B; Jakubowski Edward M; Mioduszewski Robert J; Doctor Bhupendra P
Efficacy of human serum butyrylcholinesterase against sarin vapor.
Chemico-biological interactions 2008;175(1-3):267-72.
2008: Coleman Brian R; Ratcliffe Ruthie H; Oguntayo Samuel A; Shi Xuerong; Doctor Bhupendra P; Gordon Richard K; Nambiar Madhusoodana P
[+]-Huperzine A treatment protects against N-methyl-D-aspartate-induced seizure/status epilepticus in rats.
Chemico-biological interactions 2008;175(1-3):387-95.
2008: Chilukuri Nageswararao; Sun Wei; Parikh Kalpana; Naik Ramachandra S; Tang Lin; Doctor Bhupendra P; Saxena Ashima
A repeated injection of polyethyleneglycol-conjugated recombinant human butyrylcholinesterase elicits immune response in mice.
Toxicology and applied pharmacology 2008;231(3):423-9.
2008: Doctor Bhupendra P; Tsim Karl W K; Siow Nina L
The IXth International Meeting on Cholinesterases, Suzhou, People's Republic of China, 6 to 10 May 2007.
Chemico-biological interactions 2008;175(1-3):1-2.
2008: Haigh Julian R; Johnston Scott R; Peppernay Adam; Mattern Patrick J; Garcia Gregory E; Doctor Bhupendra P; Gordon Richard K; Aisen Paul S
Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase.
Chemico-biological interactions 2008;175(1-3):380-6.
2008: Haigh Julian R; Lefkowitz Lee J; Capacio Benedict R; Doctor Bhupendra P; Gordon Richard K
Advantages of the WRAIR whole blood cholinesterase assay: comparative analysis to the micro-Ellman, Test-mate ChE, and Michel (DeltapH) assays.
Chemico-biological interactions 2008;175(1-3):417-20.
2008: Naik Ramachandra S; Doctor Bhupendra P; Saxena Ashima
Comparison of methods used for the determination of cholinesterase activity in whole blood.
Chemico-biological interactions 2008;175(1-3):298-302.
2008: Chilukuri Nageswararao; Duysen Ellen G; Parikh Kalpana; Sun Wei; Doctor Bhupendra P; Lockridge Oksana; Saxena Ashima
Adenovirus-mediated gene transfer of human butyrylcholinesterase results in persistent high-level transgene expression in vivo.
Chemico-biological interactions 2008;175(1-3):327-31.
2008: Curtin Bryan F; Seetharam Karthik I; Dhoieam Pilin; Gordon Richard K; Doctor Bhupendra P; Nambiar Madhusoodana P
Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines.
Journal of cellular biochemistry 2008;103(5):1524-35.
2007: Katos Alexandre M; Conti Michele L; Moran Theodore S; Gordon Richard K; Doctor Bhupendra P; Sciuto Alfred M; Nambiar Madhusoodana P
Abdominal bloating and irritable bowel syndrome like symptoms following microinstillation inhalation exposure to chemical warfare nerve agent VX in guinea pigs.
Toxicology and industrial health 2007;23(4):231-40.
2007: Rezk Peter E; Graham Jacob R; Moran Theodore S; Gordon Richard K; Sciuto Alfred M; Doctor Bhupendra P; Nambiar Madhusoodana P
Acute toxic effects of nerve agent VX on respiratory dynamics and functions following microinsillation inhalation exposure in guinea pigs.
Inhalation toxicology 2007;19(3):291-302.
2007: Nambiar Madhusoodana P; Gordon Richard K; Rezk Peter E; Katos Alexander M; Wajda Nikolai A; Moran Theodore S; Steele Keith E; Doctor Bhupendra P; Sciuto Alfred M
Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX.
Toxicology and applied pharmacology 2007;219(2-3):142-50.
2006: Godkar P B; Gordon R K; Ravindran A; Doctor B P
Celastrus paniculatus seed oil and organic extracts attenuate hydrogen peroxide- and glutamate-induced injury in embryonic rat forebrain neuronal cells.
Phytomedicine : international journal of phytotherapy and phytopharmacology 2006;13(1-2):29-36.
2006: Saxena Ashima; Sun Wei; Luo Chunyuan; Myers Todd M; Koplovitz Irwin; Lenz David E; Doctor Bhupendra P
Bioscavenger for protection from toxicity of organophosphorus compounds.
Journal of molecular neuroscience : MN 2006;30(1-2):145-8.
2005: Sun Wei; Doctor B P; Saxena Ashima
Safety and pharmacokinetics of human serum butyrylcholinesterase in guinea pigs.
Chemico-biological interactions 2005;157-158():428-9.
2005: Tonduli Laura S; Doctor Bhupendra P; Saxena Ashima
An ex vivo approach for the evaluation of reversible inhibitors as potential pretreatments against organophosphate toxicity.
Chemico-biological interactions 2005;157-158():426-7.
2005: Luo Chunyuan; Dawson Maureen; Chambers Carolyn; Chilukuri Nageswararao; Radic Zoran; Taylor Palmer; Doctor Bhupendra P; Saxena Ashima
Species-related differences in the oxime-induced reactivation of organophosphate-inhibited acetylcholinesterases.
Chemico-biological interactions 2005;157-158():393-4.
2005: Haigh Julian R; Johnston Scott R; Peters Brian M; Doctor Bhupendra P; Gordon Richard K; Adler Michael; Gall Kenneth J; Deshpande Sharad S
Inhibition of guinea pig hemi-diaphragm acetylcholinesterase activity by pyridostigmine bromide and protection against soman toxicity.
Chemico-biological interactions 2005;157-158():381-2.
2005: Nambiar M P; Curtin B F; Pal Nabaneeta; Compton J R; Doctor B P; Gordon R K
Transcriptional induction of cholinesterase expression and protection against chemical warfare nerve agents.
Chemico-biological interactions 2005;157-158():409-10.
2005: Cerasoli D M; Griffiths E M; Doctor B P; Saxena A; Fedorko J M; Greig N H; Yu Q S; Huang Y; Wilgus H; Karatzas C N; Koplovitz I; Lenz D E
In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia) as a potential nerve agent bioscavenger.
Chemico-biological interactions 2005;157-158():363-5.
2005: Doctor Bhupendra P; Saxena Ashima
Bioscavengers for the protection of humans against organophosphate toxicity.
Chemico-biological interactions 2005;157-158():167-71.
2005: Lenz David E; Maxwell Donald M; Koplovitz Irwin; Clark Connie R; Capacio Benjamin R; Cerasoli Douglas M; Federko James M; Luo Chunyuan; Saxena Ashima; Doctor Bhupendra P; Olson Carl
Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys.
Chemico-biological interactions 2005;157-158():205-10.
2005: Saxena Ashima; Sun Wei; Luo Chunyuan; Doctor Bhupendra P
Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice.
Chemico-biological interactions 2005;157-158():199-203.
2005: Gordon Richard K; Haigh Julian R; Garcia Gregory E; Feaster Shawn R; Riel Michael A; Lenz David E; Aisen Paul S; Doctor Bhupendra P
Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Chemico-biological interactions 2005;157-158():239-46.
2005: Chilukuri N; Parikh K; Sun W; Naik R; Tipparaju P; Doctor B P; Saxena A
Polyethylene glycosylation prolongs the circulatory stability of recombinant human butyrylcholinesterase.
Chemico-biological interactions 2005;157-158():115-21.
2005: Curtin Bryan F; Tetz Lauren M; Compton Jaimee R; Doctor Bhupendra P; Gordon Richard K; Nambiar Madhusoodana P
Histone acetylase inhibitor trichostatin A induces acetylcholinesterase expression and protects against organophosphate exposure.
Journal of cellular biochemistry 2005;96(4):839-49.
2005: Clark Matthew G; Sun Wei; Myers Todd M; Bansal Reeta; Doctor Bhupendra P; Saxena Ashima
Effects of physostigmine and human butyrylcholinesterase on acoustic startle reflex and prepulse inhibition in C57BL/6J mice.
Pharmacology, biochemistry, and behavior 2005;81(3):497-505.
2004: Godkar Praful B; Gordon Richard K; Ravindran Arippa; Doctor Bhupendra P
Celastrus paniculatus seed water soluble extracts protect against glutamate toxicity in neuronal cultures from rat forebrain.
Journal of ethnopharmacology 2004;93(2-3):213-9.
2004: Garcia Gregory E; Hicks Rickey P; Skanchy David; Moorad-Doctor Deborah R; Doctor Bhupendra P; Ved Haresh S
Identification and characterization of the major huperzine a metabolite in rat blood.
Journal of analytical toxicology 2004;28(5):379-83.
2004: Sevelová Lucie; Bajgar Jirí; Saxena Ashima; Doctor Bhupendra P
Protective effect of equine butyrylcholinesterase in inhalation intoxication of rats with sarin: determination of blood and brain cholinesterase activities.
Inhalation toxicology 2004;16(8):531-6.
2003: Saxena Ashima; Hur Regina S; Luo Chunyuan; Doctor Bhupendra P
Natural monomeric form of fetal bovine serum acetylcholinesterase lacks the C-terminal tetramerization domain.
Biochemistry 2003;42(51):15292-9.
2003: Godkar Praful; Gordon Richard K; Ravindran Arippa; Doctor Bhupendra P
Celastrus paniculatus seed water soluble extracts protect cultured rat forebrain neuronal cells from hydrogen peroxide-induced oxidative injury.
Fitoterapia 2003;74(7-8):658-69.
2003: Saxena Ashima; Fedorko James M; Vinayaka C R; Medhekar Rohit; Radic Zoran; Taylor Palmer; Lockridge Oksana; Doctor Bhupendra P
Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
European journal of biochemistry / FEBS 2003;270(22):4447-58.
2003: Luo Chunyuan; Leader Haim; Radic Zoran; Maxwell Donald M; Taylor Palmer; Doctor Bhupendra P; Saxena Ashima
Two possible orientations of the HI-6 molecule in the reactivation of organophosphate-inhibited acetylcholinesterase.
Biochemical pharmacology 2003;66(3):387-92.
2003: Ashani Yacov; Bhattacharjee Apurba K; Leader Haim; Saxena Ashima; Doctor Bhupendra P
Inhibition of cholinesterases with cationic phosphonyl oximes highlights distinctive properties of the charged pyridine groups of quaternary oxime reactivators.
Biochemical pharmacology 2003;66(2):191-202.
2002: Rosenberg Yvonne; Luo Chunyuan; Ashani Yacov; Doctor Bhupendra P; Fischer Randy; Wolfe Gary; Saxena Ashima
Pharmacokinetics and immunologic consequences of exposing macaques to purified homologous butyrylcholinesterase.
Life sciences 2002;72(2):125-34.
2002: Rajendran V; Saxena Ashima; Doctor Bhupendra P; Kozikowski Alan P
Synthesis of more potent analogues of the acetylcholinesterase inhibitor, huperzine B.
Bioorganic & medicinal chemistry letters 2002;12(11):1521-3.
2001: Gordon R K; Nigam S V; Weitz J A; Dave J R; Doctor B P; Ved H S
The NMDA receptor ion channel: a site for binding of Huperzine A.
Journal of applied toxicology : JAT 2001;21 Suppl 1():S47-51.
2000: Rajendran V; Prakash K R; Ved H S; Saxena A; Doctor B P; Kozikowski A P
Synthesis, chiral chromatographic separation, and biological activities of the enantiomers of 10,10-dimethylhuperzine A.
Bioorganic & medicinal chemistry letters 2000;10(21):2467-9.
1999: Luo C; Saxena A; Smith M; Garcia G; Radic Z; Taylor P; Doctor B P
Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium.
Biochemistry 1999;38(31):9937-47.
1999: Gordon R K; Feaster S R; Russell A J; LeJeune K E; Maxwell D M; Lenz D E; Ross M; Doctor B P
Organophosphate skin decontamination using immobilized enzymes.
Chemico-biological interactions 1999;119-120():463-70.
1999: Maxwell D M; Saxena A; Gordon R K; Doctor B P
Improvements in scavenger protection against organophosphorus agents by modification of cholinesterases.
Chemico-biological interactions 1999;119-120():419-28.
1999: Luo C; Saxena A; Ashani Y; Leader H; Radic Z; Taylor P; Doctor B P
Role of edrophonium in prevention of the re-inhibition of acetylcholinesterase by phosphorylated oxime.
Chemico-biological interactions 1999;119-120():129-35.
1999: Saxena A; Redman A M; Jiang X; Lockridge O; Doctor B P
Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Chemico-biological interactions 1999;119-120():61-9.
1998: LeJeune K E; Dravis B C; Yang F; Hetro A D; Doctor B P; Russell A J
Fighting nerve agent chemical weapons with enzyme technology.
Annals of the New York Academy of Sciences 1998;864():153-70.
1998: Saxena A; Viragh C; Frazier D S; Kovach I M; Maxwell D M; Lockridge O; Doctor B P
The pH dependence of dealkylation in soman-inhibited cholinesterases and their mutants: further evidence for a push-pull mechanism.
Biochemistry 1998;37(43):15086-96.
1998: Amitai G; Moorad D; Adani R; Doctor B P
Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon.
Biochemical pharmacology 1998;56(3):293-9.
1998: Luo C; Ashani Y; Doctor B P
Acceleration of oxime-induced reactivation of organophosphate-inhibited fetal bovine serum acetylcholinesterase by monoquaternary and bisquaternary ligands.
Molecular pharmacology 1998;53(4):718-26.
1998: Saxena A; Ashani Y; Raveh L; Stevenson D; Patel T; Doctor B P
Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases.
Molecular pharmacology 1998;53(1):112-22.
1998: Saxena A; Hur R; Doctor B P
Allosteric control of acetylcholinesterase activity by monoclonal antibodies.
Biochemistry 1998;37(1):145-54.
1997: Saxena A; Redman A M; Jiang X; Lockridge O; Doctor B P
Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Biochemistry 1997;36(48):14642-51.
1997: Saxena A; Maxwell D M; Quinn D M; Radic Z; Taylor P; Doctor B P
Mutant acetylcholinesterases as potential detoxification agents for organophosphate poisoning.
Biochemical pharmacology 1997;54(2):269-74.
1997: Saxena A; Raveh L; Ashani Y; Doctor B P
Structure of glycan moieties responsible for the extended circulatory life time of fetal bovine serum acetylcholinesterase and equine serum butyrylcholinesterase.
Biochemistry 1997;36(24):7481-9.
1997: Ved H S; Koenig M L; Dave J R; Doctor B P
Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate.
Neuroreport 1997;8(4):963-8.
1997: Dave J R; Koenig M L; Tortella F C; Pieringer R A; Doctor B P; Ved H S
Dodecylglycerol provides partial protection against glutamate toxicity in neuronal cultures derived from different regions of embryonic rat brain.
Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1997;30(1-2):1-13.
1997: Genovese R F; Doctor B P
Behavioral comparison of the oximes TMB-4, 2-PAM, and HI-6 in rats using operant conditioning.
Pharmacology, biochemistry, and behavior 1997;56(1):139-43.
1996: Chiang P K; Gordon R K; Tal J; Zeng G C; Doctor B P; Pardhasaradhi K; McCann P P
S-Adenosylmethionine and methylation.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1996;10(4):471-80.
1995: Grubic Z; Stalc A; Sentjurc M; Pecar S; Gentry M K; Doctor B P
Different effects of two peripheral anionic site-binding ligands on acetylcholinesterase active-site gorge topography revealed by electron paramagnetic resonance.
Biochimica et biophysica acta 1995;1249(2):155-60.
1995: Ashani Y; Radic Z; Tsigelny I; Vellom D C; Pickering N A; Quinn D M; Doctor B P; Taylor P
Amino acid residues controlling reactivation of organophosphonyl conjugates of acetylcholinesterase by mono- and bisquaternary oximes.
The Journal of biological chemistry 1995;270(11):6370-80.
1995: Gentry M K; Moorad D R; Hur R S; Saxena A; Ashani Y; Doctor B P
Characterization of monoclonal antibodies that inhibit the catalytic activity of acetylcholinesterases.
Journal of neurochemistry 1995;64(2):842-9.
1995: Mayers D L; Mikovits J A; Joshi B; Hewlett I K; Estrada J S; Wolfe A D; Garcia G E; Doctor B P; Burke D S; Gordon R K
Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strains.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(1):215-9.
1994: Saxena A; Qian N; Kovach I M; Kozikowski A P; Pang Y P; Vellom D C; Radic Z; Quinn D; Taylor P; Doctor B P
Identification of amino acid residues involved in the binding of Huperzine A to cholinesterases.
Protein science : a publication of the Protein Society 1994;3(10):1770-8.
1994: Grunwald J; Raveh L; Doctor B P; Ashani Y
Huperzine A as a pretreatment candidate drug against nerve agent toxicity.
Life sciences 1994;54(14):991-7.
1993: Wolfe A D; Chiang P K; Doctor B P; Fryar N; Rhee J P; Saeed M
Monoclonal antibody AE-2 modulates carbamate and organophosphate inhibition of fetal bovine serum acetylcholinesterase.
Molecular pharmacology 1993;44(6):1152-7.
1993: Segall Y; Waysbort D; Barak D; Ariel N; Doctor B P; Grunwald J; Ashani Y
Direct observation and elucidation of the structures of aged and nonaged phosphorylated cholinesterases by 31P NMR spectroscopy.
Biochemistry 1993;32(49):13441-50.
1993: Wasserman L; Doctor B P; Gentry M K; Taylor P
Epitope mapping of form-specific and nonspecific antibodies to acetylcholinesterase.
Journal of neurochemistry 1993;61(6):2124-32.
1993: Saxena A; Doctor B P; Maxwell D M; Lenz D E; Radic Z; Taylor P
The role of glutamate-199 in the aging of cholinesterase.
Biochemical and biophysical research communications 1993;197(1):343-9.
1993: Doctor B P; Blick D W; Caranto G; Castro C A; Gentry M K; Larrison R; Maxwell D M; Murphy M R; Schutz M; Waibel K
Cholinesterases as scavengers for organophosphorus compounds: protection of primate performance against soman toxicity.
Chemico-biological interactions 1993;87(1-3):285-93.
1993: Gentry M K; Saxena A; Ashani Y; Doctor B P
Immunochemical characterization of anti-acetylcholinesterase inhibitory monoclonal antibodies.
Chemico-biological interactions 1993;87(1-3):227-31.
1993: Cygler M; Schrag J D; Sussman J L; Harel M; Silman I; Gentry M K; Doctor B P
Relationship between sequence conservation and three-dimensional structure in a large family of esterases, lipases, and related proteins.
Protein science : a publication of the Protein Society 1993;2(3):366-82.
1993: Maxwell D M; Brecht K M; Doctor B P; Wolfe A D
Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase.
The Journal of pharmacology and experimental therapeutics 1993;264(3):1085-9.
1992: Elson H F; Gentry M K; Doctor B P
Membrane-bound acetylcholinesterase: an early differentiation marker for skeletal myoblasts.
Biochimica et biophysica acta 1992;1156(1):78-84.
1992: Wolfe A D; Blick D W; Murphy M R; Miller S A; Gentry M K; Hartgraves S L; Doctor B P
Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity.
Toxicology and applied pharmacology 1992;117(2):189-93.
1992: Maxwell D M; Castro C A; De La Hoz D M; Gentry M K; Gold M B; Solana R P; Wolfe A D; Doctor B P
Protection of rhesus monkeys against soman and prevention of performance decrement by pretreatment with acetylcholinesterase.
Toxicology and applied pharmacology 1992;115(1):44-9.
1992: Ashani Y; Peggins J O; Doctor B P
Mechanism of inhibition of cholinesterases by huperzine A.
Biochemical and biophysical research communications 1992;184(2):719-26.
1992: Elson H F; Gentry M K; Doctor B P
A microtiter assay for determining protein, acetylcholinesterase activity, and G418 (Neomycin) resistance in cultured cells.
Analytical biochemistry 1992;200(2):268-72.
1992: Chiang P K; Katzhendler J; Gordon R K; Doctor B P; Brown N D
Postganglionic nicotinic action of anatoxin-a on guinea pig ileum antagonized by thymopentin.
Advances in experimental medicine and biology 1992;311():429-30.
1991: Ashani Y; Shapira S; Levy D; Wolfe A D; Doctor B P; Raveh L
Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice.
Biochemical pharmacology 1991;41(1):37-41.
1991: Doctor B P; Raveh L; Wolfe A D; Maxwell D M; Ashani Y
Enzymes as pretreatment drugs for organophosphate toxicity.
Neuroscience and biobehavioral reviews 1991;15(1):123-8.
1990: Ogert R A; Gentry M K; Richardson E C; Deal C D; Abramson S N; Alving C R; Taylor P; Doctor B P
Studies on the topography of the catalytic site of acetylcholinesterase using polyclonal and monoclonal antibodies.
Journal of neurochemistry 1990;55(3):756-63.
1990: Doctor B P; Chapman T C; Christner C E; Deal C D; De La Hoz D M; Gentry M K; Ogert R A; Rush R S; Smyth K K; Wolfe A D
Complete amino acid sequence of fetal bovine serum acetylcholinesterase and its comparison in various regions with other cholinesterases.
FEBS letters 1990;266(1-2):123-7.
1990: Ashani Y; Gentry M K; Doctor B P
Differences in conformational stability between native and phosphorylated acetylcholinesterase as evidenced by a monoclonal antibody.
Biochemistry 1990;29(10):2456-63.
1989: Leader H; Smejkal R M; Payne C S; Padilla F N; Doctor B P; Gordon R K; Chiang P K
Binary antidotes for organophosphate poisoning: aprophen analogues that are both antimuscarinics and carbamates.
Journal of medicinal chemistry 1989;32(7):1522-8.
1989: Abramson S N; Ellisman M H; Deerinck T J; Maulet Y; Gentry M K; Doctor B P; Taylor P
Differences in structure and distribution of the molecular forms of acetylcholinesterase.
The Journal of cell biology 1989;108(6):2301-11.
1989: Raveh L; Ashani Y; Levy D; De La Hoz D; Wolfe A D; Doctor B P
Acetylcholinesterase prophylaxis against organophosphate poisoning. Quantitative correlation between protection and blood-enzyme level in mice.
Biochemical pharmacology 1989;38(3):529-34.
1989: Doctor B P; Smyth K K; Gentry M K; Ashani Y; Christner C E; de la Hoz D M; Ogert R A; Smith S W
Structural and immunochemical properties of fetal bovine serum acetylcholinesterase.
Progress in clinical and biological research 1989;289():305-16.
1988: Brown N D; Smejkal R M; Breuer E; Doctor B P; Chiang P K
Desethylaprophen: a metabolite of aprophen with antimuscarinic activities.
Journal of pharmaceutical sciences 1988;77(2):145-8.
1987: Wolfe A D; Rush R S; Doctor B P; Koplovitz I; Jones D
Acetylcholinesterase prophylaxis against organophosphate toxicity.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1987;9(2):266-70.
1986: Rush R S; Doctor B P; Wolfe A D
Kinetic investigations into the interactions of aprophen with cholinesterases and a carboxylesterase.
Biochemical pharmacology 1986;35(23):4167-70.
1986: Aarbakke J; Miura G A; Brown N D; Gray R R; Gordon R K; Doctor B P; Chiang P K
Disposition of aprophen in rats.
The Journal of pharmacy and pharmacology 1986;38(12):928-30.
1986: De la Hoz D; Doctor B P; Ralston J S; Rush R S; Wolfe A D
A simplified procedure for the purification of large quantities of fetal bovine serum acetylcholinesterase.
Life sciences 1986;39(3):195-9.
1986: Miura G A; Chiang P K; Gordon R K; Doctor B P; Twine C E; Philip A; Kepler J A; Carroll F I
Enzymatic synthesis of a false cholinergic neurotransmitter: diethylaminoethyl acetate as a muscarinic agonist analog of acetylcholine.
General pharmacology 1986;17(4):477-80.
1985: Ralston J S; Rush R S; Doctor B P; Wolfe A D
Acetylcholinesterase from fetal bovine serum. Purification and characterization of soluble G4 enzyme.
The Journal of biological chemistry 1985;260(7):4312-8.
1984: Brown N D; Gray R R; Stermer-Cox M G; Doctor B P; Hagedorn I
Stability study of HI-6 dichloride in various anticholinergic formulations.
Journal of chromatography 1984;315():389-94.
1983: Gordon R K; Padilla F N; Moore E; Doctor B P; Chiang P K
Antimuscarinic activity of aprophen.
Biochemical pharmacology 1983;32(19):2979-81.
1983: Doctor B P; Camp S; Gentry M K; Taylor S S; Taylor P
Antigenic and structural differences in the catalytic subunits of the molecular forms of acetylcholinesterase.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(18):5767-71.
1982: Gordon R K; Doctor B P; Chiang P K
A radioactive assay for acetylcholinesterase using anion-exchange disk.
Analytical biochemistry 1982;124(2):333-7.

Sign-in to see more